Pill Identifier App

Recombinate

In the US, Recombinate (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

Ingredient matches for Recombinate

Coagulation Factor VIII , Human (rDNA) is reported as an ingredient of Recombinate in the following countries:

  • Slovenia

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Recombinate in the following countries:

  • Argentina
  • Australia
  • Belgium
  • Croatia (Hrvatska)
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • New Zealand
  • Slovakia
  • Sweden
  • Switzerland
  • Taiwan
  • United States

Coagulation Factor VIII , Human (rDNA) Rurioctocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Recombinate in the following countries:

  • Japan

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)